Setting

Europe Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity

Published: 30 Jun 2021 | Report Code: 10248054 | Pages: 104

Europe biosurgery market accounted for $3,610.6 million in 2020 and will grow by 6.2% annually over 2020-2027 owing to the growth in joint reconstruction and spinal fusion, the increasing number of surgeries especially minimally invasive surgeries due to lifestyle disorders and the rise in the overweight & aging population. Highlighted with 34 tables and 50 figures, this 104-page report “Europe Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire Europe biosurgery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe biosurgery market in every aspect of the classification from perspectives of Product, Source Type, Application, and Country. Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Hemostatic Agents • Bone-graft Substitutes o Synthetic Graft Extender o Demineralized Bone Matrix o Bone Morphogenetic Proteins o Cell-Based Matrices • Surgical Sealants and Adhesives o Natural Surgical Sealing Agents o Synthetic Surgical Sealing Agents • Soft-tissue Attachments o Natural & Biological Mesh/Patch o Synthetic Mesh/Patch • Adhesion Barriers o Natural Adhesion Barriers o Synthetic Adhesion Barriers • Staple Line Reinforcement Based on Source Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Natural/Biological Products • Synthetic Products Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Orthopedic Surgery • General Surgery • Neurological Surgery • Cardiovascular Surgery • Gynecological Surgery • Other Applications Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Russia • Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of key national markets by Product, Source Type, and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): B. Braun Melsungen AG Baxter International, Inc. Becton, Dickinson and Company (C.R. Bard) Betatech Medical CryoLife Inc. CSL Limited Hemostasis LLC Integra Lifesciences Holdings Corporation Johnson & Johnson Medtronic PLC Pfizer, Inc. Sanofi S.A. Stryker Corporation (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents

1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	13
1.2.6 Market Size/Share Estimation	14
1.2.7 Research Limitations	15
1.3 Executive Summary	16
2 Market Overview and Dynamics	18
2.1 Market Size and Forecast	18
2.1.1 Impact of COVID-19 on World Economy	19
2.1.2 Impact of COVID-19 on the Market	21
2.2 Major Growth Drivers	23
2.3 Market Restraints and Challenges	27
2.4 Emerging Opportunities and Market Trends	30
2.5 Porter’s Fiver Forces Analysis	34
3 Segmentation of Europe Market by Product	38
3.1 Market Overview by Product	38
3.2 Hemostatic Agents	40
3.3 Bone-graft Substitutes	41
3.2.1 Synthetic Graft Extender	42
3.2.2 Demineralized Bone Matrix	43
3.2.3 Bone Morphogenetic Proteins	44
3.2.4 Cell-Based Matrices	45
3.4 Surgical Sealants and Adhesives	46
3.4.1 Natural Surgical Sealing Agents	47
3.4.2 Synthetic Surgical Sealing Agents	48
3.5 Soft-tissue Attachments	49
3.5.1 Natural & Biological Mesh/Patch	50
3.5.2 Synthetic Mesh/Patch	51
3.6 Adhesion Barriers	52
3.6.1 Natural Adhesion Barriers	53
3.6.2 Synthetic Adhesion Barriers	54
3.7 Staple Line Reinforcement	55
4 Segmentation of Europe Market by Source Type	56
4.1 Market Overview by Source Type	56
4.2 Natural/Biological Products	58
4.3 Synthetic Products	59
5 Segmentation of Europe Market by Application	61
5.1 Market Overview by Application	61
5.2 Orthopedic Surgery	63
5.3 General Surgery	64
5.4 Neurological Surgery	65
5.5 Cardiovascular Surgery	66
5.6 Gynecological Surgery	67
5.7 Other Applications	68
6 European Market 2020-2027 by Country	69
6.1 Overview of European Market	69
6.2 UK	72
6.3 France	74
6.4 Germany	76
6.5 Spain	78
6.6 Italy	80
6.7 Russia	82
6.8 Rest of European Market	84
7 Competitive Landscape	86
7.1 Overview of Key Vendors	86
7.2 New Product Launch, Partnership, Investment, and M&A	89
7.3 Company Profiles	90
B. Braun Melsungen AG	90
Baxter International, Inc.	92
Becton, Dickinson and Company (C.R. Bard)	93
Betatech Medical	94
CryoLife Inc.	95
CSL Limited	96
Hemostasis LLC	97
Integra Lifesciences Holdings Corporation	98
Johnson & Johnson	99
Medtronic PLC	100
Pfizer, Inc.	101
Sanofi S.A.	102
Stryker Corporation	103
RELATED REPORTS	104
List Of Tables

Table 1.  Snapshot of Europe Biosurgery Market in Balanced Perspective, 2020-2027	17
Table 2. Growth Rate of World GDP, 2020-2022	20
Table 3.  Main Product Trends and Market Opportunities in Europe Biosurgery Market	30
Table 4. Europe Biosurgery Market by Product, 2017-2027, $ mn	38
Table 5. Europe Biosurgery Market: Bone-Graft Substitutes by Type, 2017-2027, $ mn	41
Table 6. Europe Biosurgery Market: Surgical Sealants and Adhesives by Type, 2017-2027, $ mn	46
Table 7. Europe Biosurgery Market: Soft-tissue Attachments by Type, 2017-2027, $ mn	49
Table 8. Europe Biosurgery Market: Adhesion Barriers by Type, 2017-2027, $ mn	52
Table 9. Europe Biosurgery Market by Source Type, 2017-2027, $ mn	56
Table 10. Europe Biosurgery Market by Application, 2017-2027, $ mn	61
Table 11. Europe Biosurgery Market by Country, 2017-2027, $ mn	71
Table 12. UK Biosurgery Market by Product, 2017-2027, $ mn	73
Table 13. UK Biosurgery Market by Source Type, 2017-2027, $ mn	73
Table 14. UK Biosurgery Market by Application, 2017-2027, $ mn	73
Table 15. France Biosurgery Market by Product, 2017-2027, $ mn	75
Table 16. France Biosurgery Market by Source Type, 2017-2027, $ mn	75
Table 17. France Biosurgery Market by Application, 2017-2027, $ mn	75
Table 18. Germany Biosurgery Market by Product, 2017-2027, $ mn	77
Table 19. Germany Biosurgery Market by Source Type, 2017-2027, $ mn	77
Table 20. Germany Biosurgery Market by Application, 2017-2027, $ mn	77
Table 21. Spain Biosurgery Market by Product, 2017-2027, $ mn	79
Table 22. Spain Biosurgery Market by Source Type, 2017-2027, $ mn	79
Table 23. Spain Biosurgery Market by Application, 2017-2027, $ mn	79
Table 24. Italy Biosurgery Market by Product, 2017-2027, $ mn	81
Table 25. Italy Biosurgery Market by Source Type, 2017-2027, $ mn	81
Table 26. Italy Biosurgery Market by Application, 2017-2027, $ mn	81
Table 27. Russia Biosurgery Market by Product, 2017-2027, $ mn	83
Table 28. Russia Biosurgery Market by Source Type, 2017-2027, $ mn	83
Table 29. Russia Biosurgery Market by Application, 2017-2027, $ mn	83
Table 30. Biosurgery Market in Rest of Europe by Country, 2017-2027, $ mn	85
Table 31. B. Braun Melsungen AG: Company Snapshot	90
Table 32. B. Braun Melsungen AG: Business Segmentation	90
Table 33. B. Braun Melsungen AG: Product Portfolio	91
Table 34. B. Braun Melsungen AG: Revenue, 2017-2019, $ mn	91
List Of Figures

Figure 1. Research Method Flow Chart	11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027	16
Figure 4. Europe Biosurgery Market, 2017-2027, $ mn	18
Figure 5. Impact of COVID-19 on Business	21
Figure 6. Primary Drivers and Impact Factors of Europe Biosurgery Market	23
Figure 7.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	26
Figure 8. Primary Restraints and Impact Factors of Europe Biosurgery Market	27
Figure 9. Investment Opportunity Analysis	31
Figure 10. Porter’s Fiver Forces Analysis of Europe Biosurgery Market	34
Figure 11. Breakdown of Europe Biosurgery Market by Product, 2020-2027, % of Revenue	38
Figure 12. Contribution to Europe 2021-2027 Cumulative Revenue by Product, Value ($ mn) and Share (%)	39
Figure 13. Europe Biosurgery Market: Hemostatic Agents, 2017-2027, $ mn	40
Figure 14. Europe Biosurgery Market: Bone-graft Substitutes, 2017-2027, $ mn	41
Figure 15. Europe Biosurgery Market: Synthetic Graft Extender, 2017-2027, $ mn	42
Figure 16. Europe Biosurgery Market: Demineralized Bone Matrix, 2017-2027, $ mn	43
Figure 17. Europe Biosurgery Market: Bone Morphogenetic Proteins, 2017-2027, $ mn	44
Figure 18. Europe Biosurgery Market: Cell-Based Matrices, 2017-2027, $ mn	45
Figure 19. Europe Biosurgery Market: Surgical Sealants and Adhesives, 2017-2027, $ mn	46
Figure 20. Europe Biosurgery Market: Natural Surgical Sealing Agents, 2017-2027, $ mn	47
Figure 21. Europe Biosurgery Market: Synthetic Surgical Sealing Agents, 2017-2027, $ mn	48
Figure 22. Europe Biosurgery Market: Soft-tissue Attachments, 2017-2027, $ mn	49
Figure 23. Europe Biosurgery Market: Natural & Biological Mesh/Patch, 2017-2027, $ mn	50
Figure 24. Europe Biosurgery Market: Synthetic Mesh/Patch, 2017-2027, $ mn	51
Figure 25. Europe Biosurgery Market: Adhesion Barriers, 2017-2027, $ mn	52
Figure 26. Europe Biosurgery Market: Natural Adhesion Barriers, 2017-2027, $ mn	53
Figure 27. Europe Biosurgery Market: Synthetic Adhesion Barriers, 2017-2027, $ mn	54
Figure 28. Europe Biosurgery Market: Staple Line Reinforcement, 2017-2027, $ mn	55
Figure 29. Breakdown of Europe Biosurgery Market by Source Type, 2020-2027, % of Revenue	56
Figure 30. Contribution to Europe 2021-2027 Cumulative Revenue by Source Type, Value ($ mn) and Share (%)	57
Figure 31. Europe Biosurgery Market: Natural/Biological Products, 2017-2027, $ mn	58
Figure 32. Europe Biosurgery Market: Synthetic Products, 2017-2027, $ mn	59
Figure 33. Breakdown of Europe Biosurgery Market by Application, 2020-2027, % of Revenue	62
Figure 34. Contribution to Europe 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%)	62
Figure 35. Europe Biosurgery Market: Orthopedic Surgery, 2017-2027, $ mn	63
Figure 36. Europe Biosurgery Market: General Surgery, 2017-2027, $ mn	64
Figure 37. Europe Biosurgery Market: Neurological Surgery, 2017-2027, $ mn	65
Figure 38. Europe Biosurgery Market: Cardiovascular Surgery, 2017-2027, $ mn	66
Figure 39. Europe Biosurgery Market: Gynecological Surgery, 2017-2027, $ mn	67
Figure 40. Europe Biosurgery Market: Other Applications, 2017-2027, $ mn	68
Figure 41. Breakdown of European Biosurgery Market by Country, 2020 and 2027, % of Revenue	70
Figure 42. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)	71
Figure 43.  Biosurgery Market in UK, 2017-2027, $ mn	72
Figure 44.  Biosurgery Market in France, 2017-2027, $ mn	74
Figure 45.  Biosurgery Market in Germany, 2017-2027, $ mn	76
Figure 46.  Biosurgery Market in Spain, 2017-2027, $ mn	78
Figure 47.  Biosurgery Market in Italy, 2017-2027, $ mn	80
Figure 48.  Biosurgery Market in Russia, 2017-2027, $ mn	82
Figure 49.  Biosurgery Market in Rest of Europe, 2017-2027, $ mn	84
Figure 50. Growth Stage of Europe Biosurgery Industry over the Forecast Period	86
Key Players (this may not be a complete list and extra companies can be added upon request): 
B. Braun Melsungen AG
Baxter International, Inc.
Becton, Dickinson and Company (C.R. Bard)
Betatech Medical
CryoLife Inc.
CSL Limited
Hemostasis LLC
Integra Lifesciences Holdings Corporation
Johnson & Johnson
Medtronic PLC
Pfizer, Inc.
Sanofi S.A.
Stryker Corporation
 (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)